PTGS2 and neoplasm: However, while higher doses are required to obtain antitumoral effects with celecoxib alone in terms of short-term modulation of molecular markers involved in tumor growth, apoptosis, immune function or angiogenesis [16], these could not be necessary for circumventing COX-2-mediated chemoresistance mechanisms in combinational study with chemotherapy.